Impact of COVID-19 on drug services in the Western Balkans
Kateřina Škařupová
16 July 2020
Social, mental and economic consequences of the coronavirus pandemic to the vulnerable populations in SEE
services in the Western Balkans Kate ina kaupov 16 July 2020 - - PowerPoint PPT Presentation
Impact of COVID-19 on drug services in the Western Balkans Kate ina kaupov 16 July 2020 Social, mental and economic consequences of the coronavirus pandemic to the vulnerable populations in SEE Series of mini-Trendspotters on Impact of
16 July 2020
Social, mental and economic consequences of the coronavirus pandemic to the vulnerable populations in SEE
AL BH XK* ME MK RS
Source: Johns Hopkins University. Retrieved: 14/07/2020
Planning Output
Sustained focus on the region, capacity to provide rapid insights, action oriented approach.
10
emcdda.europa.eu
https://www.emcdda.europa.eu/topics/covid-19
14
15
5 10 15 20 25 30 35 40 45 jan.20 feb.20 mar.20 apr.20 maj.20 jun.20 Overall OST Total OST Methadone OST Suboxone/Buprenorphine Hospital treatment
People staring drug treatment in 2020 – total and by treatment type
People receiving drug treatment at the Toxicology and drug use treatment Clinic (MTUHC, Albania)
16
10 20 30 40 50 60 70 80 October November December January February March April May % Opioids Cannabis Cocaine Amphetamine-type stimulants Total
17
Total number of patients in OST therapy
Jan- June 2020
in OST January 855 February 881 March 885 April 884 May 890 June 882
Number of NEW patients entry in OST therapy
Jan- June 2020
patients in OST January 1 February March 2 April 9 May 2 June
18
5 10 15 20 25 30 jan.20 feb.20 mar.20 apr.20 maj.20 jun.20 Overall OST
People staring drug treatment in 2020 – all three cities
* This designation is without prejudice to positions on status, and is in line with UNSCR 1244 and the ICJ Opinion on the Kosovo declaration of independence.
19
decentralisation (all)
20
21
health
emcdda.europa.eu twitter.com/emcdda facebook.com/emcdda flickr.com/photos/emcdda youtube.com/emcddatube
https://ec.europa.eu/eusurvey/runner/Covid-19-IPA7-health
22